Article Sidebar

Submitted
May 8, 2021
Published
May 8, 2021
Download
PDF
Statistic
Read Counter : 95 Download : 55

Main Article Content

Abstract

Canthium parviflorum, belonging to the Rubiaceae was a valuable source of new secondary metabolites, jused in  ayurvedic system of medicine, for various disorders. Traditionally, various parts of Canthium parviflorum were used to treat oedema, dysentery, spasm, scabies, diabetes etc. It also used to eliminate uric acid as well as increase the urinary output. Current study was aim to evaluate the antigout property of ethanolic leaf extract of Canthium parviflorum. The study was conducted in both in-vitro and in-vivo models. Xantihine Oxidase inhibition method was used in in-vitro model and Potassium Oxonate induced hyperuricemia was adopted for in-vivo model. The Xanthine Oxidase inhibitor, Allopurinol was used as reference compound in both the models. Two dose levels (200 and 400mg/kg) of ethanolic leaf extract of Canthium parviflorum was evaluated against Potassium Oxonate induced hyperuricemia in SD rats. All the test drugs were administered once daily for 28 days and the protective effect was determined by measuring the plasma uric acid. In in-vitro model, the Canthium parviflorum showed Xanthine Oxidase inhibition activity and comparable as that of Allopurinol. In in-vivo model, both the doses of ethanolic leaf extract of Canthium parviflorum exhibited significant reduction in the plasma uric acid levels as compare to Potassium oxonate induced hyperuricemia in rats. From the results it was concluded that, ethanolic leaf extract of Canthium parviflorum produced antigout activity against Potassium oxonate induced gout in rats.

Keywords

Canthium parviflorum Potassium Oxonate Xanthine Oxidase Antigout Activity

Article Details

How to Cite
Asokan Balakrishnan Ramajayam, Sengottuvelu Singaravel, & Jaikumar Sankarapillai. (2021). Protective effect of Canthium parviflorum against potassium oxonate induced hyperuricemia in rats. International Journal of Research in Pharmacology & Pharmacotherapeutics, 7(3), 228-232. https://doi.org/10.61096/ijrpp.v7.iss3.2018.228-232
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. [1]. Dalbeth N, Merriman TR, Stamp LK. Gout, Lancet, 388(10055), 2016, 2039–52.
  2. [2]. McCarty DJ, Hollander JL. Identification of urate crystals in gouty synovial fluid. Ann Intern Med, 54, 1961, 452–60.
  3. [3]. Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: Prevalence, incidence and risk factors. Nat Rev Rheumatol, 11(11), 2015, 649–62.
  4. [4]. Mandal AK, Mount DB. The molecular physiology of uric acid homeostasis, Annu Rev Physiol, 77, 2015, 323–45.
  5. [5]. Singh JA. Challenges faced by patients in gout treatment: A qualitative study. J Clin Rheumatol: Practical Rep Rheum Musculo skelet Dis, 20(3), 2014, 172–4.
  6. [6]. Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors: Renaissance half a century after the discovery of Allopurinol. Pharmacol Rev, 58(1), 2006, 87–114.
  7. [7]. Kong LD, Yang C, Ge F, Wang HD, Guo YS. A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthine dehydrogenase and xanthine oxidase in mice. J Ethnopharmacol, 93(2-3), 2004, 325–330.
  8. [8]. Kirtikar KR, Basu BD, Lalit Mohan Basu. Allahabad, India, Indian Medicinal Plants, 1, 2001, 35-45.
  9. [9]. Mohideen S, Ilavarasan R, Hemalatha AN, Sasikala E. Wound healing and diuretic activities of Canthium parviflorum Lam. KR Soc Pharmacog, 5, 2006, 23-25.
  10. [10]. Anitha Roy, Geetha RV, Lakshmi T. Averrhoa bilimbi Linn-nature’s drug store a pharmacological review. Int J Drug Dev Res, 3, 2011,101-6.
  11. [11]. Ayyanar M, Sankarasivaraman K, Ignacimuthu S. Traditional herbal medicines used for the treatment of diabetes among two major tribal groups in south Tamil Nadu, India. Ethnobotanical Leaflets, 12, 2008, 276-80.
  12. [12]. Warrier PK, Nambiar VPK, Raman Kutty C. In: Indian Medicinal Plants. Vol. I. Orient Longman Publishers Ltd, Madras, 1994, 366.
  13. [13]. Parinitha M, BH Srinivasa, MB Shivanna. Medicinal plant wealth of local communities in some villages in Shimoga District of Karnataka, India. J Ethnopharmacol, 98, 2005, 307-12.
  14. [14]. Salai Senthilkumar MS, Vaidyanathan D, Sivakumar D, Ghouse Basha M. The diversity of ethnomedicinal plants used by Malayali tribals in Yelagiri hills of Eastern ghats, Tamilnadu, India. Asian J Plant Sci Res, 4, 2014, 69-80.
  15. [15]. Rajyalakshmi P. Canthium parviflorum: an underexploited carotene rich fruit. Ind J Nat Prod Res, 2, 2003, 70.
  16. [16]. John D Milton, Alvin Jose M. In vitro and in vivo anticancer evaluation of Canthium parviflorum root extracts. Int J Adv Pharm Biol Sci, 4, 2014, 17-24.
  17. [17]. Vanitha Reddy P, Lakshmi Sarkar, Asna U. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (ex vivo) by medicinal plants from western ghats. Ann Phytomed, 3, 2014, 56-61.
  18. [18]. Ramanathan R, Bhuvaneswari R, Dhandapani R. Antimicrobial activity of Canthium parviflorum Lam. and Pergularia daemia (Forsk.). Int J Comp Pharm, 9, 2013, 34-8.
  19. [19]. Karthik K, Bharath Rathna Kumar P, Venu Priya R, Sunil Kumar K, Ranjith Singh, B Rathore. Evaluation of anti-inflammatory activity of Canthium parviflorum by in vitro method. Ind J Res Pharm Biotechnol, 1, 2013, 729-30.
  20. [20]. Purushoth Prabhu T, Shine Sudev M, Deepak Venkataraman N, Clement Atlee W, Sapna S. In vitro antioxidant and antiarthritis activity of extracts and fractions of Canthium parviflorum. Eur J Biomed Pharm Sci, 2014, 533-41.
  21. [21]. Nguyen MT, Awale S, Tezuka Y, Tran QL, Watanabe H, Kadota S. Xanthine oxidase inhibitory activity of Vietnamese medicinal plants. Biol Pharm Bull, 27, 2004, 1414‑21.
  22. [22]. Watts RWE. Determination of uric acid in blood and urine. Ann Clin Biochem, 11, 1974, 103–111.